Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Indenbaum

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Vaccines|August 26, 2022
Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 VaccineItzchak Levy, Einav Gal Levin, Liraz Olmer, et al.
Vaccines|November 24, 2022
Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5-11 YearsGili Joseph, Elisheva Klein, Yaniv Lustig, et al.
Viruses|July 30, 2025
Measles Sequencing: Lessons Learned from a Large-Scale OutbreakVictoria Indenbaum, Efrat Bucris, Keren Friedman, et al.
Transplantation|November 11, 2022
Humoral Response to the Fourth BNT162b2 Vaccination and Link Between the Fourth Dose, Omicron Infection, and Disease Severity in Renal Transplant RecipientsTammy Hod, Aharon Ben-David, Eytan Mor, et al.
Journal of Hepatology|April 22, 2022
A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipientsYana Davidov, Victoria Indenbaum, Keren Tsaraf, et al.
The Journal of Infection|March 16, 2025
Circulating lncRNAs as biomarkers for severe dengue using a machine learning approachRodolfo Katz, Nguyen Minh Nam, Tulio de Lima Campos, et al.
Viruses|January 8, 2025
Persistence of Long COVID Symptoms Two Years After SARS-CoV-2 Infection: A Prospective Longitudinal Cohort StudyGili Joseph, Ili Margalit, Yael Weiss-Ottolenghi, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 16, 2022
Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - implications for the omicron variantYael Peled, Arnon Afek, Yitshak Kreiss, et al.
Nature Immunology|May 9, 2022
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine doseYaniv Lustig, Tal Gonen, Lilac Meltzer, et al.
The Lancet. Respiratory Medicine|July 5, 2021
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workersYaniv Lustig, Einav Sapir, Gili Regev-Yochay, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Vaccines|August 26, 2022
Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 VaccineItzchak Levy, Einav Gal Levin, Liraz Olmer, et al.
Vaccines|November 24, 2022
Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5-11 YearsGili Joseph, Elisheva Klein, Yaniv Lustig, et al.
Viruses|July 30, 2025
Measles Sequencing: Lessons Learned from a Large-Scale OutbreakVictoria Indenbaum, Efrat Bucris, Keren Friedman, et al.
Transplantation|November 11, 2022
Humoral Response to the Fourth BNT162b2 Vaccination and Link Between the Fourth Dose, Omicron Infection, and Disease Severity in Renal Transplant RecipientsTammy Hod, Aharon Ben-David, Eytan Mor, et al.
Journal of Hepatology|April 22, 2022
A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipientsYana Davidov, Victoria Indenbaum, Keren Tsaraf, et al.
The Journal of Infection|March 16, 2025
Circulating lncRNAs as biomarkers for severe dengue using a machine learning approachRodolfo Katz, Nguyen Minh Nam, Tulio de Lima Campos, et al.
Viruses|January 8, 2025
Persistence of Long COVID Symptoms Two Years After SARS-CoV-2 Infection: A Prospective Longitudinal Cohort StudyGili Joseph, Ili Margalit, Yael Weiss-Ottolenghi, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 16, 2022
Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - implications for the omicron variantYael Peled, Arnon Afek, Yitshak Kreiss, et al.
Nature Immunology|May 9, 2022
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine doseYaniv Lustig, Tal Gonen, Lilac Meltzer, et al.
The Lancet. Respiratory Medicine|July 5, 2021
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workersYaniv Lustig, Einav Sapir, Gili Regev-Yochay, et al.
Pageof 7